ShRNA targeting HDGF suppressed cell growth and invasion of squamous cell lung cancer

Acta Biochimica et Biophysica Sinica

Volumn 42, Issue 1, 2010, Pages 52-57

  Meng, Jie ^a,b   Xie, Wei ^a   Cao, Liming ^a   Hu, Chengping ^a   Zhen, Zhiyuan ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

Hepatoma derived growth factor; Oncogene; Squamous cell lung cancer

Indexed keywords

HEPATOMA DERIVED GROWTH FACTOR; HEPATOMA-DERIVED GROWTH FACTOR; SIGNAL PEPTIDE; SMALL INTERFERING RNA;

ANIMAL; ARTICLE; CELL CYCLE; CELL PROLIFERATION; CHEMISTRY; DRUG EFFECT; GENE EXPRESSION REGULATION; IMMUNOLOGY; LIVER CELL CARCINOMA; LIVER TUMOR; LUNG NON SMALL CELL CANCER; LUNG TUMOR; PATHOLOGY; SQUAMOUS CELL CARCINOMA; TUMOR CELL LINE;

ANIMALS; CARCINOMA, HEPATOCELLULAR; CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SQUAMOUS CELL; CELL CYCLE; CELL LINE, TUMOR; CELL PROLIFERATION; GENE EXPRESSION REGULATION, NEOPLASTIC; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; LIVER NEOPLASMS; LUNG NEOPLASMS; RNA, SMALL INTERFERING;

LENTIVIRUS;

EID: 73549104588     PISSN: 16729145     EISSN: 17457270     Source Type: Journal    
DOI: 10.1093/abbs/gmp102     Document Type: Article

References (17)

1. Renyi-Vamos F, Tovari J, Fillinger J, Timar J, Paku S, Kenessey I and Ostoros G, et al. Lymphangiogenesis correlates with lymph node metastasis, prognosis, and angiogenic phenotype in human non-small cell lung cancer. Clin Cancer Res 2005, 11: 7344-7353.
2. Okuda Y, Nakamura H, Yoshida K, Enomoto H, Uyama H, Hirotani T and Funamoto M, et al. Hepatoma-derived growth factor induces tumorigenesis in vivo through both direct angiogenic activity and induction of vascular endothelial growth factor. Cancer Sci 2003, 94: 1034-1041.
3. Zhou SJ, Xu SF, Zhang HQ and Liu ZD. Expression of HDGF and its implication in stage I non-small cell lung cancer. Zhonghua Zhong Liu Za Zhi 2007, 29: 927-930.
4. Iwasaki T, Nakagawa K, Nakamura H, Takada Y, Matsui K and Kawahara K. Hepatoma-derived growth factor as a prognostic marker in completely resected non-small-cell lung cancer. Oncol Rep 2005, 13: 1075-1080.
5. Ren H, Tang X, Lee JJ, Feng L, Everett AD, Hong WK and Khuri FR, et al. Expression of hepatoma-derived growth factor is a strong prognostic predictor for patients with early-stage non-small-cell lung cancer. J Clin Oncol 2004, 22: 3230-3237.
6. Zhang J, Ren H, Yuan P, Lang W, Zhang L and Mao L. Down-regulation of hepatoma-derived growth factor inhibits anchorage-independent growth and invasion of non-small cell lung cancer cells. Cancer Res 2006, 66: 18-23.
7. Liu L, Zhang Q, Zhang Y, Wang S and Ding Y. Lentivirus-mediated silencing of Tiam1 gene influences multiple functions of a human colorectal cancer cell line. Neoplasia 2006, 8: 917-924.
8. Kishima Y, Yamamoto H, Izumoto Y, Yoshida K, Enomoto H, Yamamoto M and Kuroda T, et al. Hepatoma-derived growth factor stimulates cell growth after translocation to the nucleus by nuclear localization signals. J Biol Chem 2002, 277: 10315-10322.
9. Everett AD, Narron JV, Stoops T, Nakamura H and Tucker A. Hepatoma-derived growth factor is a pulmonary endothelial cell-expressed angiogenic factor. Am J Physiol Lung Cell Mol Physiol 2004, 286: L1194-L1201.
10. Mori M, Morishita H, Nakamura H, Matsuoka H, Yoshida K, Kishima Y and Zhou Z, et al. Hepatoma-derived growth factor is involved in lung remodeling by stimulating epithelial growth. Am J Respir Cell Mol Biol 2004, 30: 459-469.
11. Yamamoto S, Tomita Y, Hoshida Y, Takiguchi S, Fujiwara Y, Yasuda T and Doki Y, et al. Expression of hepatoma-derived growth factor is correlated with lymph node metastasis and prognosis of gastric carcinoma. Clin Cancer Res 2006, 12: 117-122.
12. Chang KC, Tai MH, Lin JW, Wang CC, Huang CC, Hung CH and Chen CH, et al. Hepatoma-derived growth factor is a novel prognostic factor for gastrointestinal stromal tumors. Int J Cancer 2007, 121: 1059-1065.
13. Yoshida K, Tomita Y, Okuda Y, Yamamoto S, Enomoto H, Uyama H and Ito H, et al. Hepatoma-derived growth factor is a novel prognostic factor for hepatocellular carcinoma. Ann Surg Oncol 2006, 13: 159-167. (Pubitemid 43157409)
14. Hu TH, Lin JW, Chen HH, Liu LF, Chuah SK and Tai MH. The expression and prognostic role of hepatoma-derived growth factor in colorectal stromal tumors. Dis Colon Rectum 2009, 52: 319-326.
15. Uyama H, Tomita Y, Nakamura H, Nakamori S, Zhang B, Hoshida Y and Enomoto H, et al. Hepatoma-derived growth factor is a novel prognostic factor for patients with pancreatic cancer. Clin Cancer Res 2006, 12: 6043-6048. (Pubitemid 44703767)
16. Mao J, Xu Z, Fang Y, Wang H, Xu J, Ye J and Zheng S, et al. Hepatoma-derived growth factor involved in the carcinogenesis of gastric epithelial cells through promotion of cell proliferation by Erk1/2 activation. Cancer Sci 2008, 99: 2120-2127.
17. Tsang TY, Tang WY, Tsang WP, Co NN, Kong SK and Kwok TT. Down regulation of hepatoma-derived growth factor activates the Bad mediated apoptotic pathway in human cancer cells. Apoptosis 2008, 13: 1135-1147.